Jose Arevalo, MD
Ophthalmology · Baltimore, MDNPI 1376919639
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $32,743 of the $40,893 with a category attached, or 80.1%. It is spread thinly across 14 manufacturers, the largest accounting for just 21.1%. Reporting peaked in 2019 at $15,443 and has fallen 71.3% since, to $4,437 in 2025. Among ophthalmology clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 64 payments — averaging $638.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Topcon Healthcare, Inc.$9K
- Dutch Ophthalmic Research Center (international) B.v.$8K
- Genentech USA, Inc.$6K
- AbbVie$5K
- Dutch Ophthalmic, USA$5K
- Eyepoint US, Inc.$4K
- plus $3K from 8 others
Across 11 payments — averaging $6118.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Topcon Healthcare, Inc.$59K
- F. Hoffmann-la Roche AG$8K
What the payments were for
- Consulting fees$32,74380%
- Speaking & faculty fees$3,0007%
- Travel & lodging$1,6824%
- Food & beverage$3,4698%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Topcon Healthcare, Inc. | 10 | $8,636 |
| Dutch Ophthalmic Research Center (international) B.v. | 2 | $8,250 |
| Genentech USA, Inc. | 12 | $6,426 |
| AbbVie(2 entities) | 8 | $5,346 |
| Dutch Ophthalmic, USA | 3 | $5,262 |
| Eyepoint US, Inc. | 9 | $3,587 |
| Genentech, Inc. | 5 | $2,366 |
| Apellis Pharmaceuticals, Inc. | 5 | $334 |
| Astellas Pharma US Inc | 3 | $240 |
| Alimera Sciences, Inc. | 3 | $199 |
| Alcon | 1 | $98 |
| Bausch & Lomb Americas Inc. | 1 | $72 |
| Samsara Vision | 1 | $40 |
| Neurotech Pharmaceuticals, Inc. | 1 | $38 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVA Ophthalmic Surgical System$8,250
- EVA, combined machine$5,262
- OCT TRITON$4,315
- OCT MAESTRO$4,315
- SUSVIMO$3,611
- VABYSMO$2,496
- OZURDEX$2,250
- YUTIQ$1,863
- EYP-1901$1,606
- Izervay$109
- Iluvien$104
How this compares
$40,893 in reported general payments places this provider in the 90th percentile of 493 ophthalmology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 15 | $572 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 16 | $382 |
| Ketorolac Tromethamine | 15 | $274 |
| Dorzolamide Hcl | 11 | $108 |
| Latanoprost | 11 | $98 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Baltimore
- Alfred SommerBaltimore$2.9M
- Richard AdlerBaltimore$2.7M
- Peter McDonnellBaltimore$1.4M
- Esen AkpekBaltimore$782K
- Neil BresslerBaltimore$265K
- Adrienne ScottBaltimore$170K
- Jennifer ThorneBaltimore$128K
- Earl CravenBaltimore$120K
- Peter CampochiaroBaltimore$103K
- Gail SchwartzBaltimore$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.